Amber Tong
Endpoints News senior editor Amber Tong is leaving the biopharma news site for a new opportunity.
In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the U.S. and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases.
Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage.
Tong is a graduate of Rice University, with a degree in anthropology.
Priscilla Ellington has been hired by Business Insider as vice president of BI Live, its…
Pia Sarkar, deputy global business editor at The Associated Press, was installed as the new…
Cybersecurity Dive has hired Eric Geller to be a senior reporter. He will start on April 21.…
Bloomberg News is one of the biggest financial and business news organizations in the world.…
Bloomberg News is looking for a dynamic, versatile, and passionate journalist to join our DC…
This reporter will cover Long Island’s commercial real estate market and retail industry, with a…